Biomedical

Electrochemical Synthesis of the In Human S-oxide Metabolites of Phenothiazine-Containing Antipsychotic Medications




  Peer Reviewed

Abstract

Key Questions

1. What is the main focus of this study?

The study focuses on the electrochemical synthesis of S-oxide metabolites of phenothiazine-containing antipsychotic medications, specifically investigating 2-chlorophenothiazine (2CPTZ) and chlorpromazine (CPZ).

2. What techniques were used in this research?

The study employed structure-electroactivity relationship (SeAR) analysis, cyclic voltammetry studies, electrosynthesis with varying applied currents, metabolite profiling, and computational predictive analysis.

3. What were the main findings regarding the electrosynthesis of PTZ metabolites?

The research identified optimal conditions for electrosynthesis, including the use of a constant current of 1.0 mA for CPZ metabolite synthesis. The study successfully isolated and characterized sulfoxide and sulfone metabolites of 2CPTZ and CPZ.

4. How does this research contribute to the field of antipsychotic medication?

This study provides insights into the electrochemical synthesis of S-oxide metabolites of phenothiazine-containing antipsychotic medications, which can contribute to a better understanding of drug metabolism and potential side effects of these medications.

Abstract

This study focuses on the electrochemical synthesis of S-oxide metabolites of phenothiazine-containing antipsychotic medications. The research explores the structure-electroactivity relationship (SeAR) and cyclic voltammetry studies of 2-chlorophenothiazine (2CPTZ) and chlorpromazine (CPZ). The study investigates the influence of applied current variations on the electrosynthesis of phenothiazine (PTZ) metabolites and provides metabolite profiling and sulfoxidation mechanism insights. Additionally, the research includes computational predictive analysis and electrochemical detection of metabolites (CP-EDM) of PTZs.